As of 4:00pm ET
| +1.96 / +4.21%|
The 4 analysts offering 12-month price forecasts for Five Prime Therapeutics Inc have a median target of 62.00, with a high estimate of 65.00 and a low estimate of 55.00. The median estimate represents a +27.76% increase from the last price of 48.53.
The current consensus among 5 polled investment analysts is to Buy stock in Five Prime Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.